Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transcatheter Arterial ChEmoembolization”

131 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 131 results

Not applicableUnknownNCT04161287
What this trial is testing

Comparison of Efficacy in SBRT of HCC ≤5 cm With or Without TACE

Who this might be right for
Small Hepatocellular CarcinomaStereotactic Body Radiation TherapyTranscatheter Arterial Chemoembolization
Beijing 302 Hospital 330
Not applicableStudy completedNCT00820157
What this trial is testing

Cytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 120
Testing effectiveness (Phase 2)UnknownNCT02638857
What this trial is testing

Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Recurrence Hepatocellular CarcinomaAdvanced Hepatocellular Carcinoma
Second Military Medical University 60
Not applicableUnknownNCT02921139
What this trial is testing

Comparing Re-TACE Versus SABR for Post-prior-TACE Incompletely Regressed HCC: a Randomized Controlled Trial (TASABR)

Who this might be right for
Hepatocellular Carcinoma(HCC)
Dalin Tzu Chi General Hospital 120
Testing effectiveness (Phase 2)UnknownNCT03510416
What this trial is testing

Efficacy and Safety of Apatinib Combined With TACE in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization
Shanghai Zhongshan Hospital 22
Not applicableUnknownNCT05889949
What this trial is testing

Microvascular Invasion for Guiding Treatment of Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma

Who this might be right for
RadiomicsHepatocellular Carcinoma (HCC)Transcatheter Arterial Chemoembolization (TACE)+2 more
Sun Yat-sen University 200
Not applicableStudy completedNCT05352204
What this trial is testing

Effect of Tumor Micronecrosis on Postoperative Transcatheter Arterial Chemoembolization in Patients With Hepatocellular Carcinomas

Who this might be right for
Carcinoma, Hepatocellular
Zhejiang University 900
Not applicableUnknownNCT06023147
What this trial is testing

A Real-world Study of the Short-term Efficacy and Safety of E-TACE in Patients With Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Xuhua Duan 298
Not applicableStudy completedNCT03784469
What this trial is testing

Effectiveness of Positioning on Back Pain After TACE Among Patients With HCC

Who this might be right for
Liver CancerTranscatheter Arterial Chemoembolization
National Taiwan University Hospital 80
Testing effectiveness (Phase 2)Ended earlyNCT00576056
What this trial is testing

Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC

Who this might be right for
Carcinoma, Hepatocellular
University of Pittsburgh 19
Not applicableUnknownNCT06483594
What this trial is testing

Prediction and Prognostic Analysis of Liver Abscess Formation After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma (CHANCE 2407)

Who this might be right for
TACEHCC - Hepatocellular CarcinomaLiver Abscess
Shengjing Hospital 400
Testing effectiveness (Phase 2)UnknownNCT04799548
What this trial is testing

A Phase II Study of TACE Plus PD-1 Antibody in the Locally Advanced Stomach Adenocarcinoma

Who this might be right for
Advanced Gastric Cancer
Shanghai Zhongshan Hospital 71
Testing effectiveness (Phase 2)UnknownNCT05842317
What this trial is testing

Lenvatinib Plus Tislelizumab With or Without TACE in First-line Treatment of Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma
Peking Union Medical College Hospital 60
Not applicableUnknownNCT02150317
What this trial is testing

Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 180
Testing effectiveness (Phase 2)UnknownNCT04911959
What this trial is testing

Study of TACE Combined With Lenvatinib to Prevent Postoperative Recurrence in Patients With MVI Positive HCC

Who this might be right for
Hepatocellular CarcinomaLenvatinib
Second Affiliated Hospital, Zhejiang University, School of Medicine 50
Not applicableStudy completedNCT00630240
What this trial is testing

Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial Chemoembolization

Who this might be right for
Hepatocellular Carcinoma
Kaohsiung Medical University Chung-Ho Memorial Hospital 53
Post-approval studies (Phase 4)UnknownNCT05670561
What this trial is testing

Effects of Esketamine on Acute Abdominal Pain After TACE in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaTranscatheter Arterial ChemoembolizationPain
The Second Affiliated Hospital of Chongqing Medical University 60
Not applicableStudy completedNCT07562763
What this trial is testing

Estimation and Prediction of Individual Benefit From Postoperative Adjuvant Transcatheter Arterial Chemoembolization For Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)Transarterial ChemoembolizationAdjuvant Therapy+2 more
Anhui Provincial Hospital 1,005
Not applicableLooking for participantsNCT05072041
What this trial is testing

Safety and Efficacy of Degradable Microsphere in Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Next Biomedical Co., Ltd. 150
Early research (Phase 1)Study completedNCT04592029
What this trial is testing

TACE Combined With Sintilimab and Bevacizumab for Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 36
Next Page